Assenagon Asset Management
KYNB

Assenagon Asset Management’s Kyntra Bio KYNB Stock Holding History

Assenagon Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,074
Closed -$109K – 1184
2025
Q1 		$109K Hold
14,074
– – ﹤0.01% 1128
2024
Q4 		$186K Sell
14,074
-16,633
-54% -$155K ﹤0.01% 1282
2024
Q3 		$307K Buy
+30,707
New +$463K ﹤0.01% 1296
2024
Q2 		– Sell
-17,154
Closed -$1.01M – 1441
2024
Q1 		$1.01M Sell
17,154
-71,920
-81% -$3.1M ﹤0.01% 1048
2023
Q4 		$1.97M Hold
89,074
– – 0.01% 937
2023
Q3 		$1.92M Buy
89,074
+29,566
+50% +$1.16M 0.01% 858
2023
Q2 		$4.02M Buy
59,508
+5,725
+11% +$2.37M 0.01% 557
2023
Q1 		$25.1M Buy
+53,783
New +$28.5M 0.09% 194
2022
Q4 		– Sell
-20,542
Closed -$6.68M – 1388
2022
Q3 		$6.68M Sell
20,542
-18,374
-47% -$5.92M 0.03% 424
2022
Q2 		$10.3M Buy
38,916
+29,929
+333% +$7.65M 0.04% 360
2022
Q1 		$2.7M Buy
8,987
+6,322
+237% +$2.2M 0.01% 726
2021
Q4 		$939K Buy
+2,665
New +$830K ﹤0.01% 1050
2020
Q2 		– Sell
-2,322
Closed -$2.02M – 1154
2020
Q1 		$2.02M Sell
2,322
-561
-19% -$558K 0.02% 357
2019
Q4 		$3.09M Buy
+2,883
New +$2.94M 0.02% 321
2019
Q3 		– Sell
-920
Closed -$1.04M – 908
2019
Q2 		$1.04M Sell
920
-1,347
-59% -$1.47M 0.01% 706
2019
Q1 		$3.08M Buy
2,267
+396
+21% +$537K 0.03% 409
2018
Q4 		$2.17M Buy
+1,871
New +$2.1M 0.02% 424

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Assenagon Asset Management's KYNB Position: Q2 2025 in Review

Assenagon Asset Management sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 14,074 shares — an estimated $109K sold.

Assenagon Asset Management first reported a position in KYNB in Q4 2018 and held it in 17 quarters. The position peaked at $25.1M in Q1 2023. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

  • Assenagon Asset Management reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
  • Assenagon Asset Management sold 14,074 Kyntra Bio shares in Q2 2025, an estimated $109K.
  • Assenagon Asset Management first reported a position in Kyntra Bio in Q4 2018 and held it in 17 quarters.
  • Assenagon Asset Management's Kyntra Bio position peaked at $25.1M in Q1 2023.
  • 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on Assenagon Asset Management's 13F filing for Q2 2025, filed 11 Jul 2025.